Lang I, Kurz R, Geyer G, Tragl K H
II. Medizinische Universitätsklinik, Universität Wien, Austria.
Horm Metab Res. 1988 Sep;20(9):574-8. doi: 10.1055/s-2007-1010888.
63 non-obese healthy subjects aged 18 to 95 years were investigated for age-dependence of GHRH-stimulated GH-secretion. In addition, priming of GH-secretion with three oral doses of propranolol (3 x 80 mg, the last dose 2 hours prior to the second GHRH-bolus) was carried out in 15 subjects below 40 years and 13 subjects older than 70 years. We found that mean maximal incremental GH-levels were inversely correlated with chronological age (r = -0.44, P = 0.001) of the probands. Propranolol premedication caused a significant rise of both basal and peak GHRH-induced relative increases in all subjects tested, whereas GHRH-induced relative increases of GH remained unchanged. In a well selected group of non-obese healthy subjects stimulated GH-secretion is found to undergo an aging process that is supposed to be of pituitary and suprapituitary origin. Priming GH-secretion with a beta-Blocker is possible both in young and very old healthy subjects and is likely to affect the basal GH secretory tone and not GHRH-stimulated GH-secretion.
对63名年龄在18至95岁之间的非肥胖健康受试者进行了生长激素释放激素(GHRH)刺激的生长激素(GH)分泌的年龄依赖性研究。此外,对15名40岁以下和13名70岁以上的受试者,给予三次口服普萘洛尔(3×80mg,最后一剂在第二次GHRH推注前2小时服用)以启动GH分泌。我们发现,先证者的平均最大增量GH水平与实际年龄呈负相关(r = -0.44,P = 0.001)。普萘洛尔预处理使所有受试对象的基础和GHRH诱导峰值的相对增加均显著升高,而GHRH诱导的GH相对增加保持不变。在一组精心挑选的非肥胖健康受试者中,发现刺激的GH分泌会经历一个衰老过程,这个过程被认为起源于垂体和垂体上。在年轻和非常年老的健康受试者中,用β受体阻滞剂启动GH分泌都是可行的,并且可能影响基础GH分泌状态,而不影响GHRH刺激的GH分泌。